DWN12088

DRUG3 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

Idiopathic Pulmonary Fibrosis

Phase 1

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

CompletedNCT04888728

Daewoong Pharmaceutical Co. LTD.Idiopathic Pulmonary Fibrosis

Start: 2021-06-30End: 2021-07-27Updated: 2021-08-04

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

CompletedNCT04888715

Daewoong Pharmaceutical Co. LTD.Idiopathic Pulmonary Fibrosis

Start: 2021-07-23End: 2021-08-18Updated: 2021-09-23

Phase 2

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Active, not recruitingNCT05389215

Daewoong Pharmaceutical Co. LTD.Idiopathic Pulmonary Fibrosis

Start: 2022-07-29End: 2027-01-30Target: 102Updated: 2026-07-16